These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35625835)

  • 1. PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma.
    Lee BH; Kim JH; Kang KW; Lee SR; Park Y; Sung HJ; Kim BS
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer.
    Boissière-Michot F; Chateau MC; Thézenas S; Guiu S; Bobrie A; Jacot W
    Front Immunol; 2022; 13():1058424. PubMed ID: 36544779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.
    Smazynski J; Hamilton PT; Thornton S; Milne K; Wouters MCA; Webb JR; Nelson BH
    Gynecol Oncol; 2020 Jul; 158(1):167-177. PubMed ID: 32446718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGIT.
    Diong SJ; Jashnani A; Drake AW; Bee C; Findeisen F; Dollinger G; Wang F; Rajpal A; Strop P; Lee PS
    MAbs; 2023; 15(1):2253788. PubMed ID: 37675979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD155 Overexpression Correlates With Poor Prognosis in Primary Small Cell Carcinoma of the Esophagus.
    Zhao K; Ma L; Feng L; Huang Z; Meng X; Yu J
    Front Mol Biosci; 2020; 7():608404. PubMed ID: 33490104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT.
    Sun Y; Li T; Ding L; Wang J; Chen C; Liu T; Liu Y; Li Q; Wang C; Huo R; Wang H; Tian T; Zhang C; Pan B; Zhou J; Fan J; Yang X; Yang W; Wang B; Guo W
    Hepatology; 2024 May; ():. PubMed ID: 38779918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD155, an onco-immunologic molecule in human tumors.
    Gao J; Zheng Q; Xin N; Wang W; Zhao C
    Cancer Sci; 2017 Oct; 108(10):1934-1938. PubMed ID: 28730595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD226 on γδ T cells is lower in advanced chronic lymphocytic leukemia and correlates with IgA, IgG and LDH levels.
    Zarobkiewicz MK; Lehman N; Kowalska W; Dąbrowska I; Bojarska-Junak A
    Adv Clin Exp Med; 2024 May; ():. PubMed ID: 38819939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma.
    Lozano E; Mena MP; Díaz T; Martin-Antonio B; León S; Rodríguez-Lobato LG; Oliver-Caldés A; Cibeira MT; Bladé J; Prat A; Rosiñol L; Fernández de Larrea C
    Clin Cancer Res; 2020 Sep; 26(17):4688-4698. PubMed ID: 32513837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD155 in tumor progression and targeted therapy.
    Zhan M; Zhang Z; Zhao X; Zhang Y; Liu T; Lu L; Li XY
    Cancer Lett; 2022 Oct; 545():215830. PubMed ID: 35870689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.
    Fionda C; Abruzzese MP; Zingoni A; Soriani A; Ricci B; Molfetta R; Paolini R; Santoni A; Cippitelli M
    BMC Cancer; 2015 Jan; 15():17. PubMed ID: 25609078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor intrinsic and extrinsic immune functions of CD155.
    O'Donnell JS; Madore J; Li XY; Smyth MJ
    Semin Cancer Biol; 2020 Oct; 65():189-196. PubMed ID: 31883911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer.
    Peng YP; Xi CH; Zhu Y; Yin LD; Wei JS; Zhang JJ; Liu XC; Guo S; Fu Y; Miao Y
    Oncotarget; 2016 Oct; 7(41):66586-66594. PubMed ID: 27626490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.
    Sun H; Huang Q; Huang M; Wen H; Lin R; Zheng M; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
    Hepatology; 2019 Jul; 70(1):168-183. PubMed ID: 30411378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance.
    Zhang H; Zhang Y; Dong J; Li B; Xu C; Wei M; Wu J; Wei J
    Mol Ther Oncolytics; 2021 Mar; 20():12-22. PubMed ID: 33575467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma).
    Sun Y; Luo J; Chen Y; Cui J; Lei Y; Cui Y; Jiang N; Jiang W; Chen L; Chen Y; Kuang Y; Tang K; Ke Z
    Int Immunopharmacol; 2020 Mar; 80():106198. PubMed ID: 31954274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
    Sanchez-Correa B; Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Durán E; Alonso C; Solana R; Tarazona R
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies.
    Li W; Deng C; Yang H; Tian X; Chen L; Liu Q; Gao C; Lu X; Wang G; Peng Q
    Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37491355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer.
    Stamm H; Oliveira-Ferrer L; Grossjohann EM; Muschhammer J; Thaden V; Brauneck F; Kischel R; Müller V; Bokemeyer C; Fiedler W; Wellbrock J
    Oncoimmunology; 2019; 8(12):e1674605. PubMed ID: 31741778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma.
    Lozano E; Mena MP; Garrabou G; Cardus O; Díaz T; Moreno DF; Mañé Pujol J; Oliver-Caldés A; Battram A; Tovar N; Cibeira MT; Rodríguez-Lobato LG; Bladé J; Fernández de Larrea C; Rosinol L
    Clin Cancer Res; 2024 Jul; ():. PubMed ID: 38990101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.